Literature DB >> 25450033

A prospective, multicenter evaluation of predictive factors for positive surgical margins after nephron-sparing surgery for renal cell carcinoma: the RECORd1 Italian Project.

Riccardo Schiavina1, Sergio Serni2, Andrea Mari2, Alessandro Antonelli3, Riccardo Bertolo4, Giampaolo Bianchi5, Eugenio Brunocilla6, Marco Borghesi6, Marco Carini2, Nicola Longo7, Giuseppe Martorana6, Vincenzo Mirone7, Giuseppe Morgia8, Francesco Porpiglia4, Bernardo Rocco9, Bruno Rovereto10, Claudio Simeone3, Mario Sodano3, Carlo Terrone11, Vincenzo Ficarra12, Andrea Minervini2.   

Abstract

BACKGROUND: The purpose of this study was to evaluate the predictors of positive margins in one of the largest available prospective multi-institutional studies. PATIENTS AND METHODS: We evaluated all patients who underwent NSS for radiologically diagnosed kidney tumors between January 2009 and December 2012 at 19 urological Italian centers (Registry of Conservative Renal Surgery [RECORd] project). Preoperative and anthropometric data, comorbidities, intraoperative and postoperative outcomes, and histological findings were analyzed. The negative and PSMs were compared according to the clinical and surgical variables. Multivariable logistic regression models were applied to analyze predictors of PSMs.
RESULTS: Eight hundred consecutive patients were evaluated. Seven hundred sixty-one (95.1%) and 39 patients (4.9%) achieved negative and PSMs, respectively. Patients with PSMs were significantly older compared with those with negative margins (median age: 66.6 vs. 61.8 years, respectively; P = .001). A higher incidence of PSMs was observed when NSS was performed for renal masses located in the upper pole (P = .001). A lower rate of PSMs was found in patients treated with simple enucleation rather than standard PN (1.6% vs. 7.4%, respectively; P < .0001). A greater incidence of PSMs was found in Fuhrman 3/4 tumors (11.3%; P < .0001). At multivariable analysis, age (odds ratio [OR], 1.04; P = .01), upper pole tumor location (OR, 2.85; P = .005), standard PN (OR, 3.45; P = .004), and Fuhrman 3-4 nuclear grade (OR, 4.81; P = .001) were found to be independent predictors of PSMs.
CONCLUSION: In our multi-institutional report, young age, simple enucleation, middle or lower tumor location, and low-grade tumor were demonstrated to be independent predictors of negative SMs.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Partial nephrectomy; Positive margin; Predictors; Renal cancer; Simple tumor enucleation

Mesh:

Year:  2014        PMID: 25450033     DOI: 10.1016/j.clgc.2014.08.008

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN: 1558-7673            Impact factor:   2.872


  12 in total

Review 1.  Contemporary Experience with Partial Nephrectomy for Stage T2 or Greater Renal Tumors.

Authors:  Shaheen Alanee; Michelle Herberts; Bradley Holland; Danuta Dynda
Journal:  Curr Urol Rep       Date:  2016-01       Impact factor: 3.092

2.  Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.

Authors:  Firas G Petros; Michael J Metcalfe; Kai-Jie Yu; Sarp K Keskin; Bryan M Fellman; Courtney M Chang; Cindy Gu; Pheroze Tamboli; Surena F Matin; Jose A Karam; Christopher G Wood
Journal:  World J Urol       Date:  2018-02-27       Impact factor: 4.226

3.  Predictors of positive surgical margins in patients undergoing partial nephrectomy: A large single-center experience.

Authors:  Ercan Malkoç; Matthew J Maurice; Önder Kara; Daniel Ramirez; Ryan J Nelson; Julien Dagenais; Khaled Fareed; Amr Fergany; Robert J Stein; Pascal Mouracade; Jihad H Kaouk
Journal:  Turk J Urol       Date:  2019-01-01

4.  Tumor Enucleation for Renal Cell Carcinoma.

Authors:  Zachary L Smith; S Bruce Malkowicz
Journal:  J Kidney Cancer VHL       Date:  2015-04-04

5.  Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.

Authors:  Yasmin Abu-Ghanem; Jacob Ramon; Raanan Berger; Issac Kaver; Edi Fridman; Raya Leibowitz-Amit; Zohar A Dotan
Journal:  World J Surg Oncol       Date:  2017-11-02       Impact factor: 2.754

6.  Long-Term Oncologic Outcomes After Laparoscopic and Robotic Tumor Enucleation for Renal Cell Carcinoma.

Authors:  Wen Dong; Xiong Chen; Ming Huang; Xu Chen; Ming Gao; Dehua Ou; Kaiwen Li; Chenyang Wang; Shaoxu Wu; Hao Liu; Weibin Xie; Wenlian Xie; Steven C Campbell; Tianxin Lin; Jian Huang
Journal:  Front Oncol       Date:  2021-01-14       Impact factor: 6.244

7.  Open Partial Nephrectomy with Zero Ischaemia Using a Supra 12th Rib Miniflank Incision: A Minimally Invasive Open Approach for Small Renal Masses.

Authors:  Syed Ali Ehsanullah; Abida Sultana; Brian Kelly; Charlotte Dunford; Zaheer Shah
Journal:  Adv Urol       Date:  2021-12-31

8.  Evaluation of the Surgical Margin Threshold for Avoiding Recurrence after Partial Nephrectomy in Patients with Renal Cell Carcinoma.

Authors:  Jongsoo Lee; Jinu Kim; Jong Chan Kim; Won Sik Ham; Woong Kyu Han; Koon Ho Rha; Young Deuk Choi; Won Sik Jang
Journal:  Yonsei Med J       Date:  2022-02       Impact factor: 2.759

9.  Predictors of Positive Surgical Margins after Robot-Assisted Partial Nephrectomy for Localized Renal Tumors: Insights from a Large Multicenter International Prospective Observational Project (The Surface-Intermediate-Base Margin Score Consortium).

Authors:  Fabrizio Di Maida; Riccardo Campi; Brian R Lane; Ottavio De Cobelli; Francesco Sanguedolce; Georgios Hatzichristodoulou; Alessandro Antonelli; Antonio Andrea Grosso; Sabrina Noyes; Oscar Rodriguez-Faba; Frank X Keeley; Johan Langenhuijsen; Gennaro Musi; Tobias Klatte; Marco Roscigno; Bulent Akdogan; Maria Furlan; Claudio Simeone; Nihat Karakoyunlu; Martin Marszalek; Umberto Capitanio; Alessandro Volpe; Sabine Brookman-May; Jürgen E Gschwend; Marc C Smaldone; Robert G Uzzo; Alexander Kutikov; Andrea Minervini
Journal:  J Clin Med       Date:  2022-03-23       Impact factor: 4.241

10.  Partial Nephrectomy, a Comparison between Different Modalities: A Tertiary Care Center Experience.

Authors:  Ahmed Al Asker; Abdulmalik Addar; Mohammed Alghamdi; Saud Alawad; Mohammed Alharbi; Saeed Bin Hamri; Nasser Albqami; Abdullah Alkhayal; Khaled Alrabeeah
Journal:  J Kidney Cancer VHL       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.